Analyst consensus rating
Skye Bioscience Analyst Rating: none
Direct answer
Skye Bioscience's consensus rating is none.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $68.00.
Forecast evidence checked November 12, 2026.
Get free Skye Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.92
- Average price target
- $68.00
- High price target
- $160.00
- Low price target
- $16.00
- Low target gap
- +1,641%
- Target upside
- +7,299.3%
- High target gap
- +17,310.2%
- Target range width
- 15,669.2%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- November 12, 2026
- Valid through
- November 19, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Skye Bioscience?
Skye Bioscience has a verified none consensus. The same dataset has an average price target of $68.00.
How far are Skye Bioscience's low and high targets from the recorded price?
The low target implies +1,641%, while the high target implies +17,310.2%.
How many analysts are included in Skye Bioscience's consensus?
The verified consensus includes 4 analysts.
How is Skye Bioscience's target upside or downside calculated?
The average target of $68.00 is divided by the recorded price of $0.92, then one is subtracted to produce +7,299.3%. This does not guarantee a future return.
When was Skye Bioscience's analyst forecast verified?
The data was verified on 2026-11-12. The dataset is valid through 2026-11-19.